Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - DoubtfulReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Cash & Equivalents (2016 - 2026)

Exponent's Cash & Equivalents history spans 17 years, with the latest figure at $221.9 million for Q1 2026.

  • For the quarter ending Q1 2026, Cash & Equivalents fell 14.28% year-over-year to $221.9 million, compared with a TTM value of $221.9 million through Jan 2026, down 14.28%, and an annual FY2026 reading of $221.9 million, down 14.28% over the prior year.
  • Cash & Equivalents for Q1 2026 was $221.9 million at Exponent, up from $207.4 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $258.9 million in Q1 2025, with the low at $125.6 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $190.3 million, with a median of $195.2 million recorded in 2023.
  • Year-over-year, Cash & Equivalents crashed 45.76% in 2022 and then soared 60.25% in 2024.
  • Tracing EXPO's Cash & Equivalents over 5 years: stood at $161.5 million in 2022, then rose by 15.91% to $187.2 million in 2023, then increased by 17.4% to $219.7 million in 2024, then dropped by 5.61% to $207.4 million in 2025, then rose by 7.02% to $221.9 million in 2026.
  • Per Business Quant, the three most recent readings for EXPO's Cash & Equivalents are $221.9 million (Q1 2026), $207.4 million (Q4 2025), and $231.8 million (Q3 2025).